(Q58856680)

English

Liposomal amphotericin B for complicated visceral leishmaniasis (kala-azar) in eastern Sudan: how effective is treatment for this neglected disease?

scientific article published on 17 January 2014

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24433217%20AND%20SRC:MED&resulttype=core&format=json

5 March 2020

Liposomal amphotericin B for complicated visceral leishmaniasis (kala-azar) in eastern Sudan: how effective is treatment for this neglected disease? (English)

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24433217%20AND%20SRC:MED&resulttype=core&format=json

5 March 2020

visceral leishmaniasis

1 reference

based on heuristic

inferred from title

1 reference

based on heuristic

inferred from title

8

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24433217%20AND%20SRC:MED&resulttype=core&format=json

5 March 2020

Johan van Griensven

2

object named as

Johan van Griensven

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24433217%20AND%20SRC:MED&resulttype=core&format=json

5 March 2020

13

object named as

Rony Zachariah

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24433217%20AND%20SRC:MED&resulttype=core&format=json

5 March 2020

François Chappuis

3

object named as

François Chappuis

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24433217%20AND%20SRC:MED&resulttype=core&format=json

5 March 2020

author name string

Annick Antierens

4

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24433217%20AND%20SRC:MED&resulttype=core&format=json

5 March 2020

Ann Mumina

5

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24433217%20AND%20SRC:MED&resulttype=core&format=json

5 March 2020

Omar Hammam

6

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24433217%20AND%20SRC:MED&resulttype=core&format=json

5 March 2020

Philippa Boulle

7

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24433217%20AND%20SRC:MED&resulttype=core&format=json

5 March 2020

Mubarak Alnour

9

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24433217%20AND%20SRC:MED&resulttype=core&format=json

5 March 2020

Marcel Manzi

11

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24433217%20AND%20SRC:MED&resulttype=core&format=json

5 March 2020

Walter Kizito

12

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24433217%20AND%20SRC:MED&resulttype=core&format=json

5 March 2020

Niven A Salih

1

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24433217%20AND%20SRC:MED&resulttype=core&format=json

5 March 2020

Mousab S Elhag

10

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24433217%20AND%20SRC:MED&resulttype=core&format=json

5 March 2020

publication date

17 January 2014

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24433217%20AND%20SRC:MED&resulttype=core&format=json

5 March 2020

Tropical Medicine and International Health

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24433217%20AND%20SRC:MED&resulttype=core&format=json

5 March 2020

19

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24433217%20AND%20SRC:MED&resulttype=core&format=json

5 March 2020

2

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24433217%20AND%20SRC:MED&resulttype=core&format=json

5 March 2020

146-152

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24433217%20AND%20SRC:MED&resulttype=core&format=json

5 March 2020

Leishmaniasis worldwide and global estimates of its incidence

1 reference

https://api.crossref.org/works/10.1111%2FTMI.12238

21 January 2018

Liposomal amphotericin B as a treatment for human leishmaniasis

1 reference

https://api.crossref.org/works/10.1111%2FTMI.12238

21 January 2018

Liposomal amphotericin B for the treatment of visceral leishmaniasis

1 reference

https://api.crossref.org/works/10.1111%2FTMI.12238

21 January 2018

Visceral leishmaniasis: what are the needs for diagnosis, treatment and control?

1 reference

https://api.crossref.org/works/10.1111%2FTMI.12238

21 January 2018

High mortality among older patients treated with pentavalent antimonials for visceral leishmaniasis in East Africa and rationale for switch to liposomal amphotericin B.

1 reference

https://api.crossref.org/works/10.1111%2FTMI.12238

21 January 2018

Conflict and kala-azar: determinants of adverse outcomes of kala-azar among patients in southern Sudan

1 reference

https://api.crossref.org/works/10.1111%2FTMI.12238

21 January 2018

Ecology and control of the sand fly vectors of Leishmania donovani in East Africa, with special emphasis on Phlebotomus orientalis

1 reference

https://api.crossref.org/works/10.1111%2FTMI.12238

21 January 2018

Cost-effectiveness analysis of combination therapies for visceral leishmaniasis in the Indian subcontinent

1 reference

https://api.crossref.org/works/10.1111%2FTMI.12238

21 January 2018

Unresponsiveness to AmBisome in some Sudanese patients with kala-azar.

1 reference

https://api.crossref.org/works/10.1111%2FTMI.12238

21 January 2018

Increasing failure of miltefosine in the treatment of Kala-azar in Nepal and the potential role of parasite drug resistance, reinfection, or noncompliance

1 reference

https://api.crossref.org/works/10.1111%2FTMI.12238

21 January 2018

Ethiopian visceral leishmaniasis: generic and proprietary sodium stibogluconate are equivalent; HIV co-infected patients have a poor outcome.

1 reference

https://api.crossref.org/works/10.1111%2FTMI.12238

21 January 2018

Limited effectiveness of high-dose liposomal amphotericin B (AmBisome) for treatment of visceral leishmaniasis in an Ethiopian population with high HIV prevalence

1 reference

https://api.crossref.org/works/10.1111%2FTMI.12238

21 January 2018

Liposomal amphotericin B (AmBisome) in the treatment of complicated kala-azar under field conditions

1 reference

https://api.crossref.org/works/10.1111%2FTMI.12238

21 January 2018

Combination therapy for visceral leishmaniasis

1 reference

https://api.crossref.org/works/10.1111%2FTMI.12238

21 January 2018

A randomized comparison of branded sodium stibogluconate and generic sodium stibogluconate for the treatment of visceral leishmaniasis under field conditions in Sudan

1 reference

https://api.crossref.org/works/10.1111%2FTMI.12238

21 January 2018

Identifiers

10.1111/TMI.12238

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24433217%20AND%20SRC:MED&resulttype=core&format=json

5 March 2020

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24433217%20AND%20SRC:MED&resulttype=core&format=json

5 March 2020

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q58856680&oldid=1970430575"